tiprankstipranks
Advertisement
Advertisement

CVS Group strengthens board with appointment of Laura Hagan as independent director

Story Highlights
  • CVS Group appoints Laura Hagan as independent non-executive director to bolster board expertise.
  • Hagan joins key CVS board committees, reinforcing governance and supporting the group’s growth focus.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CVS Group strengthens board with appointment of Laura Hagan as independent director

Meet Samuel – Your Personal Investing Prophet

The latest update is out from CVS Group plc ( (GB:CVSG) ).

CVS Group plc, the UK- and Australia-focused veterinary services provider, has appointed Laura Hagan as an Independent Non-Executive Director effective 1 May 2026. Hagan, who currently serves on the board of FeverTree Drinks plc and was until recently Chief People Officer at Deliveroo plc, brings extensive experience in people leadership, organisation design, international expansion and technology-enabled customer service from roles at Gymshark, Tate & Lyle and Dyson.

Following her appointment, Hagan will join CVS’s Remuneration, Audit and Risk, and Nomination Committees, further strengthening the governance structure of the London-listed group. Chair David Wilton said her arrival, alongside recent board additions, enhances the board’s skills mix and listed company expertise, supporting CVS’s growth ambitions and its focus on talent development, leadership and customer service across its expanding veterinary operations.

The most recent analyst rating on (GB:CVSG) stock is a Hold with a £13.40 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on CVSG Stock

According to Spark, TipRanks’ AI Analyst, CVSG is a Neutral.

The score is primarily supported by solid financial performance, led by strong free cash flow growth and improved leverage. This is meaningfully offset by weak technicals (broad downtrend despite oversold readings) and a relatively high P/E with a low dividend yield.

To see Spark’s full report on CVSG stock, click here.

More about CVS Group plc

CVS Group plc is a UK-listed veterinary group and a leading provider of veterinary services in the UK and Australia. The company operates more than 475 veterinary practices, including specialist referral hospitals and out-of-hours sites, and runs diagnostic laboratories and the Animed Direct online retail business. It employs around 9,000 staff, including 2,500 veterinary surgeons and 3,300 nurses.

Average Trading Volume: 490,813

Technical Sentiment Signal: Buy

Current Market Cap: £848.2M

See more insights into CVSG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1